LINC-ROR and neoplasm: Notably, LINC-ROR demonstrated potential ceRNA activity targeting other tumor-suppressor miRNAs, including miR-205, miR-181a, miR-99b, and let-7a-5p [79,268], reducing their effective concentrations [79,177,268], and protect core transcription factors in CSCs [269].